Jo Ann Wilson

Title: Jo Ann Wilson: Innovating in Pharmaceutical Processes

Introduction:

Jo Ann Wilson, based in San Francisco, CA, is a prolific inventor in the field of pharmaceuticals. With 11 patents to her name, she has made significant contributions in the development of processes for preparing quinoline compounds and pharmaceutical compositions. Currently working with the renowned company Exelixis, Inc., Jo Ann Wilson has collaborated with talented colleagues such as Khalid Ali Shah and Sriram Naganathan to advance innovative research in the industry.

Latest Patents:

One of Jo Ann Wilson's recent patents is centered around processes for preparing quinoline compounds and pharmaceutical compositions. These compounds, such as formula I or pharmaceutically acceptable salts thereof, hold immense potential in the field of medicine. The patent describes the specific variations in substituents and functional groups, offering insights into their synthesis and potential applications.

Another patent focuses on C-met (hepatocyte growth factor receptor) modulator pharmaceutical compositions. Jo Ann Wilson's invention discloses pharmaceutical compositions and unit dosage forms that contain a compound (I) known to modulate the C-met pathway. Modulating this pathway holds promise in the treatment of various diseases and conditions.

Career Highlights:

Jo Ann Wilson has excelled in her career by continuously pushing the boundaries of innovation in pharmaceutical processes. Notably, her work with Exelixis, Inc., a prominent pharmaceutical company, has yielded remarkable results in patenting novel compounds and compositions. Her patents serve as a testament to her expertise, dedication, and creativity.

Collaborations:

Innovation thrives through collaboration, and Jo Ann Wilson has had the privilege of working alongside accomplished colleagues. Notably, she has collaborated with Khalid Ali Shah and Sriram Naganathan, who have contributed their expertise and insights to their collective projects. Such collaborations highlight the importance of team effort and the synergy that emerges from diverse perspectives.

Conclusion:

Jo Ann Wilson's contribution to the field of pharmaceuticals is commendable, reflected through her numerous patents and collaborations. Her expertise in processes for preparing quinoline compounds and pharmaceutical compositions showcases her innovative thinking and problem-solving abilities. As she continues to harness the power of collaboration and push the boundaries of research, the future of pharmaceutical advancements looks promising under her guidance.